Search - tctmd.com

Displaying 201 - 210 of 210

Sort: Relevancy | Date

News Conference News ESC 2015

Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes

Yael L. Maxwell

September 01, 2015

News Industry News

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

August 20, 2015

News Daily News

Novel Antisense Inhibitor Cuts High Triglyceride Levels

August 13, 2015

News Daily News

Poor Responders to Statins at Risk for CAD Progression

March 11, 2015

News Conference News AHA 2014

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

November 16, 2014

News Daily News

Una Dosis Alta de Atorvastatina podría prevenir la Lesión Renal inducida por Contraste en las PCI Voluntarias

L.A. McKeown

November 18, 2012

News Daily News

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

L.A. McKeown

November 18, 2012

News Conference News

Different Agents Show Potential as Adjuncts to PCI

Jason Kahn

May 19, 2011

News Daily News

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

Jason Kahn

April 11, 2011

CME

Advertisement

Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

Novel Antisense Inhibitor Cuts High Triglyceride Levels

Poor Responders to Statins at Risk for CAD Progression

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

Una Dosis Alta de Atorvastatina podría prevenir la Lesión Renal inducida por Contraste en las PCI Voluntarias

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

Different Agents Show Potential as Adjuncts to PCI

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content